Marina Willwacher

Marina Willwacher (Ilg) is an accomplished professional in medicinal chemistry with extensive experience in research and leadership roles. Currently serving as the Director of Medicinal Chemistry Global Strategies, Technologies, and Operations at Boehringer Ingelheim since May 2017, Marina leads a research group focused on various aspects of drug discovery, including parallel synthesis, automation, and analytics. Previous roles at Boehringer Ingelheim include Principal Scientist and Research Scientist, contributing significantly to drug discovery programs addressing conditions such as NASH and obesity. Marina's academic foundation includes a PhD from Max Planck Institute for Coal Research, a Master of Science, and a Bachelor of Science in Chemistry from Ludwig-Maximilians-Universität München.